Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

HEMOSTEMIX INC.

HMTXF
Current price
0.072 USD +0.003 USD (+4.35%)
Last closed 0.043 EUR
Company
ISIN CA4236943060
Sector Healthcare
Industry Biotechnology
Exchange F
Capitalization 11 125 122 EUR
Yield for 12 month -20.62 %
1Y
3Y
5Y
10Y
15Y
HMTXF
21.11.2021 - 28.11.2021

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada. Address: 707-7th Avenue SW, Calgary, AB, Canada, T2P 3H6

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures HMTXF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -1 548 315 EUR
Operating Margin TTM
PE Ratio
Return On Assets TTM -349.24 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price
Revenue TTM
Book Value -0.097 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.01 EUR
Diluted Eps TTM -0.01 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics HMTXF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History HMTXF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation HMTXF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -1.5246
Price Book MRQ

Financials HMTXF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators HMTXF

For 52 weeks

0.019 EUR 0.068 EUR
50 Day MA 0.035 EUR
Shares Short Prior Month
200 Day MA 0.036 EUR
Short Ratio
Shares Short
Short Percent